Your session is about to expire
← Back to Search
Radiation
UVA1 radiation treatment for Cutaneous Lupus Erythematosus
N/A
Waitlist Available
Led By Benjamin F Chong, MD, MSCS
Research Sponsored by Ben Chong
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
Study Summary
This study is evaluating whether a type of light therapy may help treat cutaneous lupus.
Eligible Conditions
- Cutaneous Lupus Erythematosus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Cutaneous Lupus Disease Area and Severity Index (CLASI) Activity Score
Secondary outcome measures
Change in Cutaneous Lupus Disease Area and Severity Index (CLASI) Damage Score
Trial Design
1Treatment groups
Experimental Treatment
Group I: UVA1 treatmentExperimental Treatment1 Intervention
Low-dose UVA1 will be applied to active cutaneous lupus lesions three times a week for 10 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
UVA1 radiation treatment
2012
N/A
~10
Find a Location
Who is running the clinical trial?
Ben ChongLead Sponsor
Daavlin CorporationUNKNOWN
Benjamin F Chong, MD, MSCSPrincipal InvestigatorUniversity of Texas Southwestern Medical Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger